chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 18.0
Sex: M
Vaccine: HEP, HEPA, MEN
Symptoms: Blood bilirubin increased
Clinical narrative: Information has been received from a health professional concerning an 18 year old male, with no medical history or known drug allergies, who on 06/12/2001 was vaccinated with one dose of hep b vaccine recombinant. Concomitant therapy that day included one dose of hep a vaccine and one dose of meningococcal polysaccharide vaccine. On 06/14/2001 lab results revealed a bilirubin of 2.94 (normal range 0-1). The pt sought unspecified medical attention. Additional info has been requested.
Age: 0.2
Sex: M
Vaccine: DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC
Symptoms: Pyrexia, Urticaria, Viral infection
Clinical narrative: Information has been received from a health professional concerning a 55 day old white male who on 10/31/01 at 09:00 was vaccinated with the 1st dose of Hib + Hep-B (lot 640930/1076L) in the left anterior thigh. Concomitant therapy on 10/31/01 included the 1st dose of Infanrix (lot 522A2) in the left thigh, the 1st dose of IPOL (lot T14502) in the right anterior thigh and the 1st dose Prevnar (lot 494141) in the right anterior thigh. On 10/31/01 at 8 to 9 hours, post vax (also reported as 6 hours), the pt developed diffuse urticaria (hives) and a fever of 103F. The pt was hospitalized on 11/1/01 for 24 hours. The dx was a viral rash. The pt recovered within 36 hours. It was noted that the pt received the 1st dose of Hep-B on 9/27/01 and the 1st dose of palivizumab (Synagis) on 11/5/01. No further information is available. From faxed additional correspondence received on 3/1/02, "It was noted that the pt had seen a pediatric allergist since this event and the allergist had considered that the child had developed a latex sensitivity or a pertussis problem. The pt was also referred to another pediatric allergist for further allergy testing. The pt subsequently experienced urticaria, fever and vaccine reaction and chemical sensitivity after vaccination with Hib. No further information is available. Upon internal review, it is noted that U200200158 may be a duplicate of U200200117. However, there are differences in the lot numbers for the products and the lab data provided. Not enough information is available to conclude that these cases are duplicates at this time.
Age: 0.2
Sex: M
Vaccine: DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC
Symptoms: Hypersensitivity, Pyrexia, Urticaria, Viral infection
Clinical narrative: Information has been received from a health professional concerning a 55 day old white male who on 10/31/01 at 09:00 was vaccinated with the 1st dose of Hib + Hep-B (lot 640930/1076L) in the left anterior thigh. Concomitant therapy on 10/31/01 included the 1st dose of Infanrix (lot 522A2) in the left thigh, the 1st dose of IPOL (lot T14502) in the right anterior thigh and the 1st dose Prevnar (lot 494141) in the right anterior thigh. On 10/31/01 at 8 to 9 hours, post vax (also reported as 6 hours), the pt developed diffuse urticaria (hives) and a fever of 103F. The pt was hospitalized on 11/1/01 for 24 hours. The dx was a viral rash. The pt recovered within 36 hours. It was noted that the pt received the 1st dose of Hep-B on 9/27/01 and the 1st dose of palivizumab (Synagis) on 11/5/01. No further information is available. From faxed additional correspondence received on 3/1/02, "It was noted that the pt had seen a pediatric allergist since this event and the allergist had considered that the child had developed a latex sensitivity or a pertussis problem. The pt was also referred to another pediatric allergist for further allergy testing. The pt subsequently experienced urticaria, fever and vaccine reaction and chemical sensitivity after vaccination with Hib. No further information is available. Upon internal review, it is noted that U200200158 may be a duplicate of U200200117. However, there are differences in the lot numbers for the products and the lab data provided. Not enough information is available to conclude that these cases are duplicates at this time.
Sex: M
Vaccine: UNK
Symptoms: Autism, Bradycardia, Neonatal apnoeic attack
Clinical narrative: The pt scored Apgars of 8 and 9 at birth and breathed room air. Within 48 hours of vaccination, he developed apnea/bradycardia. He is now autistic spectrum.
Age: 1.6
Sex: F
Vaccine: DTAP, IPV, MMR
Symptoms: Febrile convulsion, Paralysis
Clinical narrative: The pt had a febrile seizure and a Todd's paralysis which resolved in less the 4 hours.
Age: 1.08
Sex: F
Vaccine: DTAP, HEP, HIBV, MMR, PNC
Symptoms: Convulsion, Immune system disorder, Lethargy, Pharyngitis, Rash
Clinical narrative: Per mother's verbal report, the child experienced convulsions on 2/7/02, 8 days post vax. Vaccines were given on 1/30/02 and child was admitted to the hospital on 2/7/02. She was discharged on 2/10/02. Proceeding medical tests, the physician concurred that the vaccines were the cause of the child's low immunity status, hence attributable to the convulsions and the cold the child is presently experiencing. Rash "like an ant bite" was reported on arms, legs and knees, 7 days post vax. Decreased activity level was noted following immunizations; duration 1 week.
Age: 1.08
Sex: F
Vaccine: DTAP, HEP, HIBV, MMR, PNC
Symptoms: Rhinitis
Clinical narrative: Per mother's verbal report, the child experienced convulsions on 2/7/02, 8 days post vax. Vaccines were given on 1/30/02 and child was admitted to the hospital on 2/7/02. She was discharged on 2/10/02. Proceeding medical tests, the physician concurred that the vaccines were the cause of the child's low immunity status, hence attributable to the convulsions and the cold the child is presently experiencing. Rash "like an ant bite" was reported on arms, legs and knees, 7 days post vax. Decreased activity level was noted following immunizations; duration 1 week.
Age: 1.0
Sex: M
Vaccine: DTAP, HIBV, MMR, VARCEL
Symptoms: Eye swelling, Urticaria
Clinical narrative: Pt broke out in hives over all his body within 30 mins. Eyes swollen shut. ER personnel admnistered Benadryl and steroid. Swelling subsided after 1 1/2hrs. The pt went home. Follow-up call to mother the following day stating that the client is fine. On 02/08/2002 call with mom, no hives has atarax from emergency room visit for future symptoms.
Age: 44.0
Sex: F
Vaccine: ANTH, HEPA
Symptoms: Bone disorder, Carpal tunnel syndrome, Congenital foot malformation, Feeling hot, Guillain-Barre syndrome
Clinical narrative: The pt developed vague, general foot discomfort/fatigue; pain at metatarsal heads with weight bearing; intermittent lancinating pains in toes; in warm conditions, feet/toes hot and blush; in cooler conditions toes feel "like they are freezing" and ache. Bending over (to vacuum) increases paresthesias/numbness in shins/dorsal feet. Prolonged standing increases fatigue, discomfort and swelling in feet up to ankles. Fasciculations in calves are still precipitated by exertion. Treatment: Foot discomfort and swelling is greatly relieved by foot exercises and leg elevation and swimming. Neurologist assessment: Acute inflammatory polyneuropathy (AIP) or Guillain-Barre  temporally associated with influenza and anthrax vaccines; numbness paresthesias and weakness in both feet in L5-S1 distribution bilaterally secondary to residual effects of AIP; autonomic neuropathy secondary to #1 with secondary dependent edema problems; cervical herniated nucleus pulposus (C5-6 HNP) and bilateral carpal tunnel syndrome. Due to the incompatibility of this service member's medical condition with the demands of operational/remote/overseas environment, it is recommended that she be found unsuitable for such assignment. No prolonged standing, walking, running or jogging. Pt workload should not exceed 10-11 hours per day in order to allow for medical care requirements. She may need time to maintain her swimming program. Continue physical therapy. Allow use of non-confining (soft) footwear as tolerated, continue silicone orthotics with metatarsal bars (Viscoped), avoid further vaccinations unless specifically reviewed by vaccine safety assessment expert. Administer oseltamivir for influenza prophylaxis as indicated. After a LP in 10/99, Lyme neuroborreliosis was considered and she was given a course of Ceftriaxone therapy (2gms IV qd X 30 days). She noted no immediate improvement in her neurologic symptoms. By 8/00, she noted significantly increased weakness and atrophy of the intrinsic muscles of the feet. A repeat MRI in 8/00 showed findings consistent with a diffuse axonal peripheral neuropathy. She now manifests a claw foot-like deformity of the left foot. Update letter: The sensation in the feet/distal lower extremities has improved slightly with improved sensory discrimination. The strength of the foot intrinsic muscle has improved with improved foot function, toe strength and toe coordination. The autonomic neuropathy findings are still evident with shiny skin in the feet/distal lower extremities, vascular hyperreativity and intermittent dysesthesias-but the foot edema no longer seems to be a problem. Pt feels that the improvement in motor strength/function, resolution of the edema problem and control of the dysethesias is a result of a regualar physical therapy program.
Age: 44.0
Sex: F
Vaccine: ANTH, HEPA
Symptoms: Infection, Muscle atrophy, Muscular weakness, Neuropathy peripheral, Oedema peripheral
Clinical narrative: The pt developed vague, general foot discomfort/fatigue; pain at metatarsal heads with weight bearing; intermittent lancinating pains in toes; in warm conditions, feet/toes hot and blush; in cooler conditions toes feel "like they are freezing" and ache. Bending over (to vacuum) increases paresthesias/numbness in shins/dorsal feet. Prolonged standing increases fatigue, discomfort and swelling in feet up to ankles. Fasciculations in calves are still precipitated by exertion. Treatment: Foot discomfort and swelling is greatly relieved by foot exercises and leg elevation and swimming. Neurologist assessment: Acute inflammatory polyneuropathy (AIP) or Guillain-Barre  temporally associated with influenza and anthrax vaccines; numbness paresthesias and weakness in both feet in L5-S1 distribution bilaterally secondary to residual effects of AIP; autonomic neuropathy secondary to #1 with secondary dependent edema problems; cervical herniated nucleus pulposus (C5-6 HNP) and bilateral carpal tunnel syndrome. Due to the incompatibility of this service member's medical condition with the demands of operational/remote/overseas environment, it is recommended that she be found unsuitable for such assignment. No prolonged standing, walking, running or jogging. Pt workload should not exceed 10-11 hours per day in order to allow for medical care requirements. She may need time to maintain her swimming program. Continue physical therapy. Allow use of non-confining (soft) footwear as tolerated, continue silicone orthotics with metatarsal bars (Viscoped), avoid further vaccinations unless specifically reviewed by vaccine safety assessment expert. Administer oseltamivir for influenza prophylaxis as indicated. After a LP in 10/99, Lyme neuroborreliosis was considered and she was given a course of Ceftriaxone therapy (2gms IV qd X 30 days). She noted no immediate improvement in her neurologic symptoms. By 8/00, she noted significantly increased weakness and atrophy of the intrinsic muscles of the feet. A repeat MRI in 8/00 showed findings consistent with a diffuse axonal peripheral neuropathy. She now manifests a claw foot-like deformity of the left foot. Update letter: The sensation in the feet/distal lower extremities has improved slightly with improved sensory discrimination. The strength of the foot intrinsic muscle has improved with improved foot function, toe strength and toe coordination. The autonomic neuropathy findings are still evident with shiny skin in the feet/distal lower extremities, vascular hyperreativity and intermittent dysesthesias-but the foot edema no longer seems to be a problem. Pt feels that the improvement in motor strength/function, resolution of the edema problem and control of the dysethesias is a result of a regualar physical therapy program.
Age: 44.0
Sex: F
Vaccine: ANTH, HEPA
Symptoms: Pain, Paraesthesia, Polyneuropathy
Clinical narrative: The pt developed vague, general foot discomfort/fatigue; pain at metatarsal heads with weight bearing; intermittent lancinating pains in toes; in warm conditions, feet/toes hot and blush; in cooler conditions toes feel "like they are freezing" and ache. Bending over (to vacuum) increases paresthesias/numbness in shins/dorsal feet. Prolonged standing increases fatigue, discomfort and swelling in feet up to ankles. Fasciculations in calves are still precipitated by exertion. Treatment: Foot discomfort and swelling is greatly relieved by foot exercises and leg elevation and swimming. Neurologist assessment: Acute inflammatory polyneuropathy (AIP) or Guillain-Barre  temporally associated with influenza and anthrax vaccines; numbness paresthesias and weakness in both feet in L5-S1 distribution bilaterally secondary to residual effects of AIP; autonomic neuropathy secondary to #1 with secondary dependent edema problems; cervical herniated nucleus pulposus (C5-6 HNP) and bilateral carpal tunnel syndrome. Due to the incompatibility of this service member's medical condition with the demands of operational/remote/overseas environment, it is recommended that she be found unsuitable for such assignment. No prolonged standing, walking, running or jogging. Pt workload should not exceed 10-11 hours per day in order to allow for medical care requirements. She may need time to maintain her swimming program. Continue physical therapy. Allow use of non-confining (soft) footwear as tolerated, continue silicone orthotics with metatarsal bars (Viscoped), avoid further vaccinations unless specifically reviewed by vaccine safety assessment expert. Administer oseltamivir for influenza prophylaxis as indicated. After a LP in 10/99, Lyme neuroborreliosis was considered and she was given a course of Ceftriaxone therapy (2gms IV qd X 30 days). She noted no immediate improvement in her neurologic symptoms. By 8/00, she noted significantly increased weakness and atrophy of the intrinsic muscles of the feet. A repeat MRI in 8/00 showed findings consistent with a diffuse axonal peripheral neuropathy. She now manifests a claw foot-like deformity of the left foot. Update letter: The sensation in the feet/distal lower extremities has improved slightly with improved sensory discrimination. The strength of the foot intrinsic muscle has improved with improved foot function, toe strength and toe coordination. The autonomic neuropathy findings are still evident with shiny skin in the feet/distal lower extremities, vascular hyperreativity and intermittent dysesthesias-but the foot edema no longer seems to be a problem. Pt feels that the improvement in motor strength/function, resolution of the edema problem and control of the dysethesias is a result of a regualar physical therapy program.
Age: 0.08
Sex: F
Vaccine: HEP
Symptoms: Abnormal sleep-related event, Adrenal haemorrhage, Apnoea, Cough, Nasal congestion
Clinical narrative: Sudden Infant Death preceeded by nasal congestion and dry cough. Per autopsy F/U 3/27/02: The pleural surfaces are smooth and glistening with petechiae (thymic, epicardial and pleural). There is hemorrhage within the periadrenal fat of the bilateral glands. According to the parents, they awaken with the decedent in bed with them and not breathing. They call 911 and began CPR. EMS arrived and CPR continued en route to the hospital. Efforts at resuscitation were continued in the ER, but they were unsuccessful. The infant was pronounced dead at 6:30 AM on 12/1/01.
Age: 0.08
Sex: F
Vaccine: HEP
Symptoms: Petechiae, Sudden infant death syndrome
Clinical narrative: Sudden Infant Death preceeded by nasal congestion and dry cough. Per autopsy F/U 3/27/02: The pleural surfaces are smooth and glistening with petechiae (thymic, epicardial and pleural). There is hemorrhage within the periadrenal fat of the bilateral glands. According to the parents, they awaken with the decedent in bed with them and not breathing. They call 911 and began CPR. EMS arrived and CPR continued en route to the hospital. Efforts at resuscitation were continued in the ER, but they were unsuccessful. The infant was pronounced dead at 6:30 AM on 12/1/01.
Age: 0.5
Sex: M
Vaccine: DTPHIB, HEP, OPV
Symptoms: Autism, Convulsion, Drug toxicity, Epilepsy
Clinical narrative: On April 1997, the pt had his first visable seisure. DPT show was given on 03/10/1997. Most of the shots the pt was given for immunizations at this time contatined Thimerasol. The mother recently found out that her son has a metal disorders and exposure to metals can cause neurological problems. He is autistic and has epilepsy. Annual follow up states: pt has not recovered. Epilepsy was controlled after 4 years so far. Could return per doctor. Autistic. We went ahead and gave additional vaccinations required at age 6 because to date there is no absolute proof this had caused any problems and school and doctor pressured to do it. I still and will probally always question this as the cause.
Age: 34.0
Sex: F
Vaccine: FLU3
Symptoms: CSF test abnormal, Encephalitis, Headache, Injection site erythema, Multiple sclerosis
Clinical narrative: The pt had quarter-sized raised area of erythema at injection site about 1 hours, post vax, according to pt. She had a headache and occipital visual loss and congestion. MRI on 11/24/99 is consistent with ADEM. Treated with steroids. This is an addendum to the original form that I sent in on this pt on 5/16/01. It has been brought to my attention that the vaccine lot number (10163AA) written by me, may have been a misinterpretation of the actual number. The injection was given at another healthcare facility and I have been unable to talk to the nurse who actually gave the injection, to determine which of these numbers is correct. Discharge summary states brain lesion.
Age: 34.0
Sex: F
Vaccine: FLU3
Symptoms: Nasal congestion, Nuclear magnetic resonance imaging brain abnormal, Visual disturbance
Clinical narrative: The pt had quarter-sized raised area of erythema at injection site about 1 hours, post vax, according to pt. She had a headache and occipital visual loss and congestion. MRI on 11/24/99 is consistent with ADEM. Treated with steroids. This is an addendum to the original form that I sent in on this pt on 5/16/01. It has been brought to my attention that the vaccine lot number (10163AA) written by me, may have been a misinterpretation of the actual number. The injection was given at another healthcare facility and I have been unable to talk to the nurse who actually gave the injection, to determine which of these numbers is correct. Discharge summary states brain lesion.
Age: 16.0
Sex: F
Vaccine: HEP
Symptoms: Coma, Confusional state, Dizziness, Headache, Lethargy
Clinical narrative: About an hour after pt received Hep-B shot, she became lethargic and non-responsive at home. She also developed a rash on her back and chest. With EMS, pt awoke. Admitted to the hospital with orders for Solu-Medrol IVP. Attending physician at the hospital wrote that apparently because of the confusion and the misunderstanding, the pt had a 4th shot that she did not need. She did well initially and went home. Then she started to feel dizzy and became very confused. She cannot remember anything else from that point. Her memory is back basically from ER when she started to feel better. The pt admits to some sore throat 2 days earlier which resolved completely. In the hospital she complained of a mild headache. On discharge she will be given Tylenol with Codeine for headache.
Age: 16.0
Sex: F
Vaccine: HEP
Symptoms: Rash, White blood cell count increased
Clinical narrative: About an hour after pt received Hep-B shot, she became lethargic and non-responsive at home. She also developed a rash on her back and chest. With EMS, pt awoke. Admitted to the hospital with orders for Solu-Medrol IVP. Attending physician at the hospital wrote that apparently because of the confusion and the misunderstanding, the pt had a 4th shot that she did not need. She did well initially and went home. Then she started to feel dizzy and became very confused. She cannot remember anything else from that point. Her memory is back basically from ER when she started to feel better. The pt admits to some sore throat 2 days earlier which resolved completely. In the hospital she complained of a mild headache. On discharge she will be given Tylenol with Codeine for headache.
Age: 60.0
Sex: M
Vaccine: LYME
Symptoms: Arthralgia, Cyst, Hiccups, Joint swelling, Myalgia
Clinical narrative: The pt developed a high fever (106F highest), chills, hiccups, joint pains and swelling. Discharge summary states additional diagnoses of pancytopenia, myalgia, mild maxillary sinusitis, cyst of L lobe of liver, and mildly enlarged spleen.
Age: 60.0
Sex: M
Vaccine: LYME
Symptoms: Pancytopenia, Pyrexia, Sinusitis, Splenomegaly
Clinical narrative: The pt developed a high fever (106F highest), chills, hiccups, joint pains and swelling. Discharge summary states additional diagnoses of pancytopenia, myalgia, mild maxillary sinusitis, cyst of L lobe of liver, and mildly enlarged spleen.
Age: 81.0
Sex: M
Vaccine: FLU3
Symptoms: Lung disorder
Clinical narrative: A report was received on 28 February 2002 concerning an 81-year old male patient who was hospitalized for COPD exacerbation on the same day he received Fluvirin vaccine, on 04 November 1998.  The causality was stated to be possibly related. No further information was provided.
Age: 77.0
Sex: M
Vaccine: FLU3
Symptoms: Lung disorder
Clinical narrative: A report was received on 28 February 2002 concerning a 77 year old male patient who experienced exacerbation of chronic obstructive pulmonary disease 8 days after receiving Fluvirin vaccine, on 29 October 1998 The event was considered medically important. No further information was provided. The causality was stated to be possibly related.
Age: 1.08
Sex: M
Vaccine: DTAP
Symptoms: Blister, Pyrexia
Clinical narrative: Had Varicella 2/19/02. Woke up crying early am of 2/28/2002 with fever and a few spots. by morning of 2/28/2002 child is "covered" in chicken pox including face, neck, trunk, arms and legs. When asked of possible exposure to another child with chicken pox, mother stated "he never goes anywhere" and denied any known exposure. Parent had contacted doctor, prior to phone call to Shawnee County
Age: 0.75
Sex: M
Vaccine: DT, HBHEPB, IPV, PNC
Symptoms: Erythema, Rash, Rash maculo-papular
Clinical narrative: Mother called that her son broke out in red rash 5 mins after the administration. Stated that his face was "red and blotchy" raised areas. By the time arrived home, rash had disappeared. Stated son was sleeping comfortably with no breathing difficulties.
Age: 0.5
Sex: M
Vaccine: DTAP, HEP, HIBV, PNC
Symptoms: Urticaria
Clinical narrative: Patient developed hives over trunk face and extremities in evening after receiving vaccines. Atarax 5 mg every 8 hours X 4-5 days
Age: 0.3
Sex: F
Vaccine: DTAP, HIBV, IPV, PNC
Symptoms: Rash erythematous, Rash maculo-papular
Clinical narrative: Patient developed macular, papular erythematous rash that blocks over trunk, face and extremities, two days after vaccine. Patient also had several days of URI symptoms.
Age: 0.3
Sex: F
Vaccine: DTAP, HEP, HIBV, IPV
Symptoms: Vomiting
Clinical narrative: received vaccines-11:30 , 2/1/02 in office MDPA, vomited in 1440 + 1505 2/1/02, no fever, seen 1810 MDFPA -exam normal, temperature 97 degrees F, took six oz of formula in office just prior to exam-no vomiting  2/2 phone follow up-doing fine, no fever or vomiting  Note :Patient received Hepatitis B which was 3rd hepatitis B per mom and MDPA records #1-9/17/01, #2-10/25/01
Age: 1.5
Sex: M
Vaccine: DTAP, HIBV, IPV
Symptoms: Injection site erythema, Injection site mass, Injection site oedema
Clinical narrative: small knot at shot site, 1 day post shots. Significant swelling and erythema of left thigh on second day. erythema spread along the lateral side to slightly below the knee and 3/4 of the way up the thigh. Rx: Ketler 250/Scc, 1/2 tsp QID x 7d
Age: 1.0
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Pyrexia, Rash morbilliform, Vomiting
Clinical narrative: child;preexisting rash, developed fever and vomiting, morbilli form rash after MMR, varicella
Age: 47.0
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Blister, Injection site erythema, Injection site hypersensitivity, Musculoskeletal stiffness, Pain
Clinical narrative: Right deltoid given Varivax -redness and stiffness measured 4 X 3 1/4 Left forearm given PPD -reaction measured 4 3/4 x 3 1/4-itchy pain and big blisters in center Pt was given Ceftin x 8days & diprolene Lotion BID
Age: 47.0
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Pruritus
Clinical narrative: Right deltoid given Varivax -redness and stiffness measured 4 X 3 1/4 Left forearm given PPD -reaction measured 4 3/4 x 3 1/4-itchy pain and big blisters in center Pt was given Ceftin x 8days & diprolene Lotion BID
Age: 4.0
Sex: M
Vaccine: DTAP, IPV, MMR
Symptoms: Skin discolouration, Swelling
Clinical narrative: Increased swelling and discoloration of left arm down past elbow and shoulder.
Age: 0.4
Sex: F
Vaccine: DTAP, HIBV, IPV
Symptoms: Febrile convulsion, Respiratory rate increased
Clinical narrative: On 2/19/02 at 18:02 went to hospital ER. Temperature was 103.6F (ax); Respirations 30. Had had 2 seizures at home. Had seizure in ER and given Tylenol susp 120mg; O2 by IV. At 18:32, temperature 99.9F (ax). At 20:00, temperature 100F (ax). Given Motrin 50mg po. O2 discontinued. At 20:15, given Augmentin 125mg/5ml-6ml po at 04:00. Discharge temperature 98.6F (R). Discharge dx: febrile seizures, otitis media. Rx'd Augmentin bid/10 days. On 2/21/02, saw FNP and temperature was 104.7F and increased Motrin. On 2/25/02, doing ok. To get OK from PMD before next vaccines.
Age: 4.0
Sex: F
Vaccine: DTAP, IPV, MMR
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Thigh was red and swollen.
Age: 0.3
Sex: F
Vaccine: DTAP, HIBV, IPV
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Right thigh was red and swollen.
Age: 16.0
Sex: F
Vaccine: HEP
Symptoms: Hypotension, Hypotonia
Clinical narrative: At approx. 14:30 on 1/18/02, immediately after receiving 2nd Hep-B in the right arm, the client slumped to the floor from her chair. She was conscious, eyes open and her head shook 3 times and she stated "this never happened before". Her BP was checked by the NP immediately and said to be 76/50. I gave her 1/2 bottle glucose tolerance solution to drink. She stated earlier that she had only had a bag of chips to eat and that she usually feels "hot
Age: 49.0
Sex: F
Vaccine: FLU3, HEP, IPV, TYP
Symptoms: Apnoea, Choking, Fatigue, Headache, Injection site pain
Clinical narrative: Client reports "vaccines on 11/21/01 at 10:30 AM" followed by "slight headache, sore arm and felt tired". On 11/22/01, client reports she awoke at 02:30 with "choking, very sore and swollen throat and positional apnea". Client states she "took an antihistamine" and "improved in 1 1/2 hours".
Age: 49.0
Sex: F
Vaccine: FLU3, HEP, IPV, TYP
Symptoms: Pharyngeal oedema, Pharyngolaryngeal pain
Clinical narrative: Client reports "vaccines on 11/21/01 at 10:30 AM" followed by "slight headache, sore arm and felt tired". On 11/22/01, client reports she awoke at 02:30 with "choking, very sore and swollen throat and positional apnea". Client states she "took an antihistamine" and "improved in 1 1/2 hours".
Age: 25.0
Sex: M
Vaccine: HEP
Symptoms: Diarrhoea, Pyrexia
Clinical narrative: Client states he received his 1st dose of Hep-B vaccine on 1/23/02 around 18:00. He did not have any symptoms of illness prior to receiving the vaccine. He woke at midnight on 1/29/02 and had a fever of 101F and diarrhea. The diarrhea has continued. Referred to physician. (2/12/02 TC with MFR, who states this could occur again with dose #3 but it is not reason to discontinue series). Felt better on Saturday, 1/26/02. Went to work in the evening.
Age: 33.0
Sex: F
Vaccine: HEPA
Symptoms: Flushing, Hypotension
Clinical narrative: Client stated she felt "funny/flushed". Client denied nausea, dizziness, weakness or breathing difficulty. At 15:42, client self-administered 50mg Benadryl po. At 16:00, BP was 120/70; pulse 80 and client stated she still felt "funny". At 16:45, client stated she felt "fine", no longer "flushed" or any other symptoms. Client stated the injection site was "sore". Ice pack applied X 30 minutes. At 17:20, BP was 110/70, pulse 80, no further complaints. Client left clinic without assistance. On 2/13/02, client saw PCP and had no further treatment needed, no tests done and she stated injection site still "sore" but no redness, swelling or warmth to the site.
Age: 40.0
Sex: F
Vaccine: HEP
Symptoms: Pruritus, Rash macular
Clinical narrative: The day after IZ, broke out with red rash only on left side of body (same side as IZ was given). There were blotches and itching with lasted 48 hours. Started on meds and Topicort cream; Aristocort at immunization. Rash lasted 48 hours, after starting to use the creams.
Age: 4.0
Sex: F
Vaccine: DTAP, IPV, MMR
Symptoms: Cellulitis, Injection site erythema, Injection site swelling
Clinical narrative: Pt developed redness and swelling at the site of DTPA/IPV (24 hours later) on right arm. Treated with Keflex for cellulitis of right upper extremity versus local reaction.
Age: 11.0
Sex: F
Vaccine: HEPA, TYP
Symptoms: Decreased appetite, Dizziness, Nausea, Tremor
Clinical narrative: Received pedi Hep-A vaccine and Typhium VI vaccine on 6/21/01. Pt then traveled to abroad X 3 weeks. Appox. 2 weeks, post vax, the pt developed dizziness, nausea, decreased appetite and "shakiness". Per pt's mom, the pt was worked-up via blood and stool tests numerous times with (-) findings. Mother has questioned if these vaccines are associated with her daughter's clinical signs and symptoms (we doubt this). Mom called on 3/4/02 to review on-going problems occurring 2 weeks, post vax. Doubt correlation.
Age: 4.0
Sex: F
Vaccine: DTAP, IPV, MMR
Symptoms: Injection site erythema, Injection site induration, Injection site swelling, Injection site warmth
Clinical narrative: DTAP placed in left arm on 2/19/02. Pt returned with a local redness and swelling of left arm on 2/21/02. Had 11cm X 18cm of redness and warmth and 5cm X 4 1/2cm of induration. No fever.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV, MMR
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Left upper arm was red and swollen. No tenderness and no pain. Pt was running around and was very happy. Gave Benadryl and ice compress for 3 days. Advised to come back. Allergic reaction to immunizations.
Age: 25.0
Sex: M
Vaccine: TD
Symptoms: Dizziness, Nausea, Vomiting
Clinical narrative: 2 day, post vax, had nausea and vomiting and dizziness.
Age: 1.0
Sex: M
Vaccine: DTAP
Symptoms: Pyrexia
Clinical narrative: Fever of 104.2F and was taken to ER.
Age: 39.0
Sex: F
Vaccine: HEPA
Symptoms: Alanine aminotransferase increased, Antinuclear antibody positive, Aspartate aminotransferase increased
Clinical narrative: Report describes elevations of ALT and AST and a positive antinuclear antibody titer in a 39 year old female who received an injection of hep A vaccine. This report was received from the vaccinee, who is a nurse practitioner. The vaccinee submitted this report directly to VAERS. Medical history included irregular menstrual cycles and hypercholesterolemia. Concurrent medications included vitamin E 400 units daily, a multivitamin with extra folic acid, calcium, acetylsalicylic acid 81 mg daily, and an unspecified oral contraceptive. The vaccinee took the oral contraceptive in june 2001, July 2001 and August 2001 for menstrual cycle regulation. The vaccinee on 09/18/2001, received first injection of Havrix. She had "routine lab work" performed on 10/17/2001, which revealed ALT 169 U/L and AST 70 U/L. She discontinued taking vitamine E, multivitamin with extra folic acid, calcium, and acetylsalicylic acid. Ferritin, alpha-1 antitrypsin, and ceruplasmin concentrations were normal. Smooth muscle antibodies were negative. The vaccinee was non reactive for hep B surface antigen and hep C antibodies. Antinuclear antibody titer was 1:80 with a speckled pattern. Laboratory analysis performed on 11/27/2001 revealed ALT 173 U/L and AST 73 U/L. The vaccinee reported that she experienced "fleeting episodes of equilibrium disturbance." The most recent information, received on 01/14/2002, did not provide the outcomes of the events. On 4/26/02, ALT and AST concentration remained elevated at 76IU/L and 46 IU/L, respectively. The most recent info was received on 5/29/02. ALT and AST concentrations remained elevated. The vaccinee stated, "The only change is, I am now on Welchol (colesevelam) for increased cholesterol."
Age: 73.0
Sex: M
Vaccine: FLU3
Symptoms: Tracheobronchitis
Clinical narrative: A report received on 2/28/02, is concerning a 73 year old male pt who experienced life-threatening tracheobronchitis, for which he was hospitalized, 3 days after receiving Fluvirin vaccine, on 10/20/1998. The pt died subsequently. It is unclear from the report what the cause of death was. The causality was stated to be possibly related. No further information was provided.
Age: 0.2
Sex: M
Vaccine: DTAP, HBHEPB, IPV, PNC
Symptoms: Abnormal sleep-related event, Anaemia, Apnoea, Enterocolitis, Metabolic acidosis
Clinical narrative: Pt with GERD, showed apnea on monitor. (30 week preemie) Reglan and ranitidine discontinued by mom, 2 weeks ago. Found lifeless at home. EMT's in ambulance tried resuscitation and this was continued at the ER. No response.  COD: undetermined, manner of death: undetermined Per F/U 5/22/01: Lungs show petechiae bilaterally and also in thymus. Also states; child was found unresponsive in bed shared with mother and another individual. Hospital course complicated by necrotizing enterocolitis, anemia, mild hyperbilirubinemia, periodic breathing (treated with caffeine), edema and mild metabolic acidosis. Discharged after birth on caffeine, ranitidine and Reglan. The cause of death could not be determined.
Age: 0.2
Sex: M
Vaccine: DTAP, HBHEPB, IPV, PNC
Symptoms: Oedema, Petechiae
Clinical narrative: Pt with GERD, showed apnea on monitor. (30 week preemie) Reglan and ranitidine discontinued by mom, 2 weeks ago. Found lifeless at home. EMT's in ambulance tried resuscitation and this was continued at the ER. No response.  COD: undetermined, manner of death: undetermined Per F/U 5/22/01: Lungs show petechiae bilaterally and also in thymus. Also states; child was found unresponsive in bed shared with mother and another individual. Hospital course complicated by necrotizing enterocolitis, anemia, mild hyperbilirubinemia, periodic breathing (treated with caffeine), edema and mild metabolic acidosis. Discharged after birth on caffeine, ranitidine and Reglan. The cause of death could not be determined.
Age: 0.7
Sex: M
Vaccine: DTAP
Symptoms: Autism, Convulsion, Epilepsy, Speech disorder
Clinical narrative: Report describes epilepsy in an 8 month old male who received Infanrix. This report was received from the vaccinee's mother and has not been verified by a physician or other healthcare professional. Medical history, concurrent conditions, and concurrent medications were not specified. The infant received an injection of hep B vaccine at birth. In March 1997, the infant received an injection of Infanrix; it was not known if the infant had received previous injections of Infanrix. The infant also received "routine child imunizations" although, the mother was unable to recall which vaccines had been administered. Approximately one month post-immunization, in April 1997, the infant began to experience seizures. The infant was seen by a neurologist, who made a diagnosis of epilepsy. At 2 years of age, the child "would not talk." The child was seen by another physician, who made a diagnosis of autism in 1999, when the child was 3 years old. Treatment of the events was not provided. The epilepsy and autism were ongoing as of 02/22/2002. Information was received from the child's current pediatrician on 08Oct02. The Pediatrician indicated that the child was not under his care at the time of immunization. He stated, Autism and seizures may have been underlying conditions. He indicated that immunization had been delayed, but not discontinued.  Epilepsy and autism in this report are considered medically serious.
Age: 54.0
Sex: F
Vaccine: LYME
Symptoms: Unevaluable event
Clinical narrative: First vaccination 3/15/99, 2nd 4/29/99 and did not have latter vaccinations as problems were being reported, plus I was now well. Add dizziness, headache and shoulder pain, and increased fatigue.
Age: 54.5
Sex: M
Vaccine: FLU3, PPV
Symptoms: Bronchiectasis, Bronchitis chronic, Central nervous system neoplasm, Coma, Coordination abnormal
Clinical narrative: The 54.5 year old male pt developed vertigo and vomiting. After brain tumor surgery 8 week coma with meningitis, stroke sepsis, respiratory and kidney failure, permanent residuals-gait ataxia, peripheral nerve damage, bronchiectasis with ehmophysis episodes, speech and swallowing difficulties, hypotension after meals, hearing and vision damage. Per follow up letter pt did not recover. Galt ataxia, chronic bronchitis, partial swallowing paralysis. Very disapponited in how my original report was handled. The interviewer was either blindly bias or severly handicapped by lack of training as an interviewer. This is being made just in case the VAERS program is not the sham it appears to be. From top to bottom, CDC and HHS should be overlooked so as not to appear to be anothe PAC for the pharmaceutical industry.
Age: 54.5
Sex: M
Vaccine: FLU3, PPV
Symptoms: Dysphagia, Hearing impaired, Hypotension, Meningitis, Nerve injury
Clinical narrative: The 54.5 year old male pt developed vertigo and vomiting. After brain tumor surgery 8 week coma with meningitis, stroke sepsis, respiratory and kidney failure, permanent residuals-gait ataxia, peripheral nerve damage, bronchiectasis with ehmophysis episodes, speech and swallowing difficulties, hypotension after meals, hearing and vision damage. Per follow up letter pt did not recover. Galt ataxia, chronic bronchitis, partial swallowing paralysis. Very disapponited in how my original report was handled. The interviewer was either blindly bias or severly handicapped by lack of training as an interviewer. This is being made just in case the VAERS program is not the sham it appears to be. From top to bottom, CDC and HHS should be overlooked so as not to appear to be anothe PAC for the pharmaceutical industry.
Age: 54.5
Sex: M
Vaccine: FLU3, PPV
Symptoms: Renal failure, Respiratory failure, Sepsis, Speech disorder, Vertigo
Clinical narrative: The 54.5 year old male pt developed vertigo and vomiting. After brain tumor surgery 8 week coma with meningitis, stroke sepsis, respiratory and kidney failure, permanent residuals-gait ataxia, peripheral nerve damage, bronchiectasis with ehmophysis episodes, speech and swallowing difficulties, hypotension after meals, hearing and vision damage. Per follow up letter pt did not recover. Galt ataxia, chronic bronchitis, partial swallowing paralysis. Very disapponited in how my original report was handled. The interviewer was either blindly bias or severly handicapped by lack of training as an interviewer. This is being made just in case the VAERS program is not the sham it appears to be. From top to bottom, CDC and HHS should be overlooked so as not to appear to be anothe PAC for the pharmaceutical industry.
Age: 54.5
Sex: M
Vaccine: FLU3, PPV
Symptoms: Visual acuity reduced, Vomiting
Clinical narrative: The 54.5 year old male pt developed vertigo and vomiting. After brain tumor surgery 8 week coma with meningitis, stroke sepsis, respiratory and kidney failure, permanent residuals-gait ataxia, peripheral nerve damage, bronchiectasis with ehmophysis episodes, speech and swallowing difficulties, hypotension after meals, hearing and vision damage. Per follow up letter pt did not recover. Galt ataxia, chronic bronchitis, partial swallowing paralysis. Very disapponited in how my original report was handled. The interviewer was either blindly bias or severly handicapped by lack of training as an interviewer. This is being made just in case the VAERS program is not the sham it appears to be. From top to bottom, CDC and HHS should be overlooked so as not to appear to be anothe PAC for the pharmaceutical industry.
Age: 0.3
Sex: M
Vaccine: DTAP, HBHEPB, IPV, PNC
Symptoms: Cellulitis, Injection site abscess, Injection site pain
Clinical narrative: 5 days, post vax, the pt developed a sore left leg. It worsened over the next 6 days. He was admitted for IV antibiotics and radiologically guided drainage of abscess. He was discharged on the 4th day. Took 10 day course of po Keflex. He is being followed with X-rays to ensure normalization. Dx of cellulitis after immunizations.
Age: 0.1
Sex: M
Vaccine: DTP, OPV
Symptoms: Cerebral palsy, Convulsion, Crying, Hydrocephalus, Hypotonia
Clinical narrative: The pt seemed to be developing normally during his 1st 2 months. On 7/16/86, during a routine newborn check-up, the pt was given his 1st IZ of DPT and Oral Polio vaccine. Three days later, while at his grandmother's home, he began crying, stiffened up and then went limp. His grandmother was concerned and told his mother that when she returned home she should contact the doctor to report the episode. The doctor was not concerned at the time. It was within a few days from that episode that the mother and the grandmother began noticing that he would not hold his head up unassisted any longer and episodes of what the grandmother called excessive crying and seizures. The grandmother called the child's doctor to report these changes and he asked her when she noticed them. She said on or about 7/16/86, when he came to visit. The grandmother also remembers writing a letter to the MD to inquire about the episodes the child was having and the relationship to the IZ he had received. She never got a satisfactory answer from anyone regarding the strange behavior of the child. On the next visit to the doctor, 8/6/86, 3 weeks post vax, the doctor noticed that the child was not fixing on movement or objects and the eyes had searching movements. Subsequently, the child was dx'd as hydrocephalic and with cerebral palsy. After speaking with the staff at the doctor's office where the pt received the IZ's, I was told that they no longer have any records pertaining to the manufacturer or lot number of the IZ given. They also informed me that the pt was not given the same IZ after that initial injection on 7/16/86, due to a possible reaction.  Diagnosed with congenital hydrocephalus, chorioretinitis resulting in blindness, seizure activity, mental retardation, cerebral palsy-spastic
Age: 0.1
Sex: M
Vaccine: DTP, OPV
Symptoms: Muscular weakness, Musculoskeletal stiffness, Staring
Clinical narrative: The pt seemed to be developing normally during his 1st 2 months. On 7/16/86, during a routine newborn check-up, the pt was given his 1st IZ of DPT and Oral Polio vaccine. Three days later, while at his grandmother's home, he began crying, stiffened up and then went limp. His grandmother was concerned and told his mother that when she returned home she should contact the doctor to report the episode. The doctor was not concerned at the time. It was within a few days from that episode that the mother and the grandmother began noticing that he would not hold his head up unassisted any longer and episodes of what the grandmother called excessive crying and seizures. The grandmother called the child's doctor to report these changes and he asked her when she noticed them. She said on or about 7/16/86, when he came to visit. The grandmother also remembers writing a letter to the MD to inquire about the episodes the child was having and the relationship to the IZ he had received. She never got a satisfactory answer from anyone regarding the strange behavior of the child. On the next visit to the doctor, 8/6/86, 3 weeks post vax, the doctor noticed that the child was not fixing on movement or objects and the eyes had searching movements. Subsequently, the child was dx'd as hydrocephalic and with cerebral palsy. After speaking with the staff at the doctor's office where the pt received the IZ's, I was told that they no longer have any records pertaining to the manufacturer or lot number of the IZ given. They also informed me that the pt was not given the same IZ after that initial injection on 7/16/86, due to a possible reaction.  Diagnosed with congenital hydrocephalus, chorioretinitis resulting in blindness, seizure activity, mental retardation, cerebral palsy-spastic
Age: 73.0
Sex: M
Vaccine: FLU3
Symptoms: Pneumonia
Clinical narrative: A report was received on 2/28/02, concerning a 73 year old male pt who was hospitalized for pneumonia, 1 month after receiving Fluvirin vaccine, on 11/12/98. The event was considered serious. The causality was stated to be possibly related. No further information was provided.
Sex: U
Vaccine: VARCEL
Symptoms: Multiple sclerosis
Clinical narrative: Per mother "My MS was caused by son's Varicella vaccine triggering a reaction to the pox already in my system." "His vaccine triggered my MS via pox or shingles/silent"
Age: 1.0
Sex: F
Vaccine: DTAP, MMR, PNC, VARCEL
Symptoms: Pyrexia, Rash
Clinical narrative: Rash, high fever x 1 days , temperature 106.0 after shot. ?MMR
Age: 37.0
Sex: F
Vaccine: FLU3
Symptoms: Oedema
Clinical narrative: Pt called clinic at 3:00 pm-10/25/01 to report neck was swollen-(the middle of neck) had awakened this morning, coughing and founds neck to be swollen-breathing ok-swelling seemed to get worse.  Patient sent Immediate Care  Follow up:  02/26/2002: Since 10/25/01 unable to reach patient, no phone, moved.  Patient has appointment schedule to see how it went to immediate on ER.  Patient did not.  Patient here today for physical.  Patient did not pursue treatment of swollen neck, never any problem breathing.  Symptoms went away over night.    2/26/02-since 10/25/2001-unable to reach pt-no phone and moved. Pt was checked per appt. schedule to see if went to Immediate Care or ER. Pt did not. Pt here today for physical. reports did not pressure  treatment of swollen neck. Never any problem breathing. Symptoms went away over night.
Age: 7.0
Sex: F
Vaccine: DTAP, HBHEPB, PNC
Symptoms: Urticaria
Clinical narrative: Hives -9-10 days after shots , Gone 4-5 days later. No Benadryl given
Age: 1.75
Sex: F
Vaccine: MMR, PNC, VARCEL
Symptoms: Blister
Clinical narrative: Pt developed chicken pox around 2-26-02 Was seen in ER on 2-26-03
Age: 0.4
Sex: M
Vaccine: PNC
Symptoms: Eczema, Rash
Clinical narrative: Day of Prevnar shot, child develoed worsening eczema on face without breathing difficulties. No other shots given that day. That was the 2nd Prevnar shot. Pt treated with Eucerin topical cream. Mother brought child in for ambulatory care a week later. Rash was resolving but still noticeable. Child with previously known eczema.
Age: 1.0
Sex: F
Vaccine: DTAP, HIBV, IPV, MMR, PNC
Symptoms: Cerebrovascular accident, Pyrexia, Skin ulcer
Clinical narrative: Three days after vaccination the pt developed visible lesions, strokes with fever.
Age: 11.0
Sex: F
Vaccine: HEPA, TD, YF
Symptoms: Rash
Clinical narrative: Pt returns on 3/6/2002 to complete travel immunization ;menomune and Typhim (pt going to Ethiopia X 2 months. Per pt's dad, pt developed rashes 2 days after receiving the vaccines On exam, rashes noted on her forehead and trunk per dad @ no time did she have any respiratory distress. Pt did not have to take any medications for this conditions
Age: 10.0
Sex: F
Vaccine: HEP
Symptoms: Malaise, Pyrexia
Clinical narrative: The pt was brought into the doctor's office on 02/21/2002 by her father who stated that she developed a "night fever" about 2-3 pm. Also stated that she was "burning up" and did not feel well. She had fever until the next afternoon.
Age: 1.2
Sex: M
Vaccine: DTAP, HEP, HIBV, IPV, MMR
Symptoms: Infection, Pyrexia, Rash
Clinical narrative: The pt came down with low grade fever on 03/01/2002, the next day he came down wit rash, started on stomach, now also in scalp. Also on 02/28/2002 he was given Keflex for infected left great toe, also donatussin Syrup per mom once per day on 03/03/2002 and 03/04/2002.
Age: 1.08
Sex: M
Vaccine: HEP, MMR, VARCEL
Symptoms: Rash
Clinical narrative: Rash developed eight days after administration of Varivax and MMR.